Cargando…

Utility of the Neurobehavioral Cognitive Status Examination (COGNISTAT) in differentiating between depressive states in late-life depression and late-onset Alzheimer’s disease: a preliminary study

BACKGROUND: It is often difficult to differentiate between the depressive states seen in late-life depression and late-onset Alzheimer’ disease (AD) in the clinical setting. METHODS: Thirty-four outpatients were recruited, all fulfilling the criteria of aged 65 years or above, scores of 14 or more o...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsuruoka, Yoshiaki, Takahashi, Michio, Suzuki, Masatoshi, Sato, Koichi, Shirayama, Yukihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4719701/
https://www.ncbi.nlm.nih.gov/pubmed/26793267
http://dx.doi.org/10.1186/s12991-016-0091-5
_version_ 1782410964654620672
author Tsuruoka, Yoshiaki
Takahashi, Michio
Suzuki, Masatoshi
Sato, Koichi
Shirayama, Yukihiko
author_facet Tsuruoka, Yoshiaki
Takahashi, Michio
Suzuki, Masatoshi
Sato, Koichi
Shirayama, Yukihiko
author_sort Tsuruoka, Yoshiaki
collection PubMed
description BACKGROUND: It is often difficult to differentiate between the depressive states seen in late-life depression and late-onset Alzheimer’ disease (AD) in the clinical setting. METHODS: Thirty-four outpatients were recruited, all fulfilling the criteria of aged 65 years or above, scores of 14 or more on the Hamilton depression rating scale (HAM-D), and 26 or less on the Mini-Mental State Examination (MMSE). At the initial visit, they were administered the Neurobehavioral Cognitive Status Examination (COGNISTAT). At 1 month, a diagnosis of either senile depression (n = 24) or Alzheimer’ disease (n = 10) was made. RESULTS: The COGNISTAT revealed that the late-life depression group showed significantly higher scores in orientation and comprehension subtests compared with the AD group. At the study endpoint (6 months after treatment), MMSE detected significant improvements in the late-life depression group (n = 15), but no changes in the late-onset AD group (n = 7). Scores for memory, similarities, and judgment on the second COGNISTAT were significantly improved in the depressed group, whereas calculation scores deteriorated significantly in the AD group. CONCLUSION: The COGNISTAT could prove useful in differentiating late-life depression from late-onset AD, despite similar scores on MMSE.
format Online
Article
Text
id pubmed-4719701
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-47197012016-01-21 Utility of the Neurobehavioral Cognitive Status Examination (COGNISTAT) in differentiating between depressive states in late-life depression and late-onset Alzheimer’s disease: a preliminary study Tsuruoka, Yoshiaki Takahashi, Michio Suzuki, Masatoshi Sato, Koichi Shirayama, Yukihiko Ann Gen Psychiatry Primary Research BACKGROUND: It is often difficult to differentiate between the depressive states seen in late-life depression and late-onset Alzheimer’ disease (AD) in the clinical setting. METHODS: Thirty-four outpatients were recruited, all fulfilling the criteria of aged 65 years or above, scores of 14 or more on the Hamilton depression rating scale (HAM-D), and 26 or less on the Mini-Mental State Examination (MMSE). At the initial visit, they were administered the Neurobehavioral Cognitive Status Examination (COGNISTAT). At 1 month, a diagnosis of either senile depression (n = 24) or Alzheimer’ disease (n = 10) was made. RESULTS: The COGNISTAT revealed that the late-life depression group showed significantly higher scores in orientation and comprehension subtests compared with the AD group. At the study endpoint (6 months after treatment), MMSE detected significant improvements in the late-life depression group (n = 15), but no changes in the late-onset AD group (n = 7). Scores for memory, similarities, and judgment on the second COGNISTAT were significantly improved in the depressed group, whereas calculation scores deteriorated significantly in the AD group. CONCLUSION: The COGNISTAT could prove useful in differentiating late-life depression from late-onset AD, despite similar scores on MMSE. BioMed Central 2016-01-20 /pmc/articles/PMC4719701/ /pubmed/26793267 http://dx.doi.org/10.1186/s12991-016-0091-5 Text en © Tsuruoka et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Primary Research
Tsuruoka, Yoshiaki
Takahashi, Michio
Suzuki, Masatoshi
Sato, Koichi
Shirayama, Yukihiko
Utility of the Neurobehavioral Cognitive Status Examination (COGNISTAT) in differentiating between depressive states in late-life depression and late-onset Alzheimer’s disease: a preliminary study
title Utility of the Neurobehavioral Cognitive Status Examination (COGNISTAT) in differentiating between depressive states in late-life depression and late-onset Alzheimer’s disease: a preliminary study
title_full Utility of the Neurobehavioral Cognitive Status Examination (COGNISTAT) in differentiating between depressive states in late-life depression and late-onset Alzheimer’s disease: a preliminary study
title_fullStr Utility of the Neurobehavioral Cognitive Status Examination (COGNISTAT) in differentiating between depressive states in late-life depression and late-onset Alzheimer’s disease: a preliminary study
title_full_unstemmed Utility of the Neurobehavioral Cognitive Status Examination (COGNISTAT) in differentiating between depressive states in late-life depression and late-onset Alzheimer’s disease: a preliminary study
title_short Utility of the Neurobehavioral Cognitive Status Examination (COGNISTAT) in differentiating between depressive states in late-life depression and late-onset Alzheimer’s disease: a preliminary study
title_sort utility of the neurobehavioral cognitive status examination (cognistat) in differentiating between depressive states in late-life depression and late-onset alzheimer’s disease: a preliminary study
topic Primary Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4719701/
https://www.ncbi.nlm.nih.gov/pubmed/26793267
http://dx.doi.org/10.1186/s12991-016-0091-5
work_keys_str_mv AT tsuruokayoshiaki utilityoftheneurobehavioralcognitivestatusexaminationcognistatindifferentiatingbetweendepressivestatesinlatelifedepressionandlateonsetalzheimersdiseaseapreliminarystudy
AT takahashimichio utilityoftheneurobehavioralcognitivestatusexaminationcognistatindifferentiatingbetweendepressivestatesinlatelifedepressionandlateonsetalzheimersdiseaseapreliminarystudy
AT suzukimasatoshi utilityoftheneurobehavioralcognitivestatusexaminationcognistatindifferentiatingbetweendepressivestatesinlatelifedepressionandlateonsetalzheimersdiseaseapreliminarystudy
AT satokoichi utilityoftheneurobehavioralcognitivestatusexaminationcognistatindifferentiatingbetweendepressivestatesinlatelifedepressionandlateonsetalzheimersdiseaseapreliminarystudy
AT shirayamayukihiko utilityoftheneurobehavioralcognitivestatusexaminationcognistatindifferentiatingbetweendepressivestatesinlatelifedepressionandlateonsetalzheimersdiseaseapreliminarystudy